| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/09/2006 | US7041697 for the treatment of depression, anxiety, panic disorder, post-traumatic stress disorder, premenstrual disorder, attention deficit disorder, obsessive compulsive disorder, obesity, eating disorders, cocaine and alcohol addiction, sexual dysfunction |
| 05/09/2006 | US7041693 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents |
| 05/09/2006 | US7041690 Viricides; hepatitis virus infections |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II); |
| 05/09/2006 | US7041683 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041672 Substituted aryl 1, 4-pyrazine derivatives |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | US7041663 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/09/2006 | US7041235 Fluorescent diketopyrrolopyrrole analogues |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/09/2006 | CA2233666C Heterocyclic fungicides |
| 05/09/2006 | CA2205573C Enterokinetic benzamide |
| 05/04/2006 | WO2006047756A2 Substituted tetracycline compounds |
| 05/04/2006 | WO2006047504A1 Aromatic amides as inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047503A2 Inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047492A2 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 05/04/2006 | WO2006047479A2 C-fms kinase inhibitors |
| 05/04/2006 | WO2006046914A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046910A1 Novel use |
| 05/04/2006 | WO2006046778A1 3-carbamoyl-2-pyridone derivative |
| 05/04/2006 | WO2006046552A1 Novel nitrogenous heterocyclic compounds and salts thereof |
| 05/04/2006 | WO2006046071A1 Compounds and compositions useful in the treatment of neoplasia |
| 05/04/2006 | WO2006036497A3 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 05/04/2006 | WO2006027628A3 Naphthalimide derivatives as antiviral agents |
| 05/04/2006 | WO2006023573A3 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 05/04/2006 | WO2005123718A3 Benzimidazolone carboxylic acid derivatives |
| 05/04/2006 | WO2005109987A3 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 05/04/2006 | WO2005025681A3 A system for and a method of manufacturing personal golf putters |
| 05/04/2006 | US20060094737 Novel uracil derivatives and medicinal use thereof |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094732 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094711 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/04/2006 | US20060094710 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 05/04/2006 | CA2585248A1 Substituted tetracycline compounds |
| 05/04/2006 | CA2584409A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2584167A1 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 05/03/2006 | EP1652926A2 Heterologous production of polyketides |
| 05/03/2006 | EP1652841A1 Novel phenantridine analogues and their use as inhibitors of hyperproliferation of T cells and/or keratinocytes |
| 05/03/2006 | EP1651639A1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 05/03/2006 | EP1651637A1 3-amino chroman and 2-amino tetralin derivatives |
| 05/03/2006 | EP1651634A1 Imidazol derivatives of piperidine as histamine antagonists |
| 05/03/2006 | EP1651631A1 Bicyclic imidazol derivatives against flaviviridae |
| 05/03/2006 | EP1651620A2 Piperazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651613A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 05/03/2006 | EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/03/2006 | EP1651609A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651599A1 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1651592A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | EP1651220A1 2-[4- (2-hydroxymethyl-phenylamino)-piperidin-1-yl] - n-(9h-carbazol-3-yl) - acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 05/03/2006 | EP1651214A2 Benzimidazole derivatives as mek inhibitors |
| 05/03/2006 | EP1651209A2 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1546128B1 Pyrimidine derivatives as selective cox-2 inhibitors |
| 05/03/2006 | EP1444224B1 3-substituted oxindole beta-3 agonists |
| 05/03/2006 | EP1444200B1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 05/03/2006 | EP1427724B1 Novel use of substituted aminomethyl chromans |
| 05/03/2006 | EP1353904B9 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2006 | EP1248771B1 Method for preparing hydroxypicolinic acid derivatives |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1188755B1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 05/03/2006 | EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands |
| 05/03/2006 | EP1133489B9 Isonipecotamides for the treatment of integrin-mediated disorders |
| 05/03/2006 | EP0771794B1 Oxygen-containing heterocyclic compounds |
| 05/03/2006 | CN1768056A Chromenone indoles. |
| 05/03/2006 | CN1768053A Pyrazole compounds. |
| 05/03/2006 | CN1768052A Substituted pyrazole compounds |
| 05/03/2006 | CN1768051A Substituted pyrazoles |
| 05/03/2006 | CN1768050A Benzopyran compounds useful for treating inflammatory conditions |
| 05/03/2006 | CN1768049A 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
| 05/03/2006 | CN1768043A 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders. |
| 05/03/2006 | CN1768040A Isoquinoline-5-sulfonic acid amides as inhibitors of AKT (protein kinase B) |
| 05/03/2006 | CN1767828A Medicinal composition |
| 05/03/2006 | CN1767827A Remedy and/or preventive for lung diseases |
| 05/03/2006 | CN1765890A Modulators of dopamine neurotransmission |
| 05/03/2006 | CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 05/02/2006 | US7038063 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis |
| 05/02/2006 | US7038046 Triazine derivatives and their use as sunscreens |
| 05/02/2006 | US7037931 CCK-1 receptor modulators |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037642 Removing compounds from blood products with porous particles immobilized in a matrix |
| 05/02/2006 | CA2263267C Process for the preparation of glycidyl ethers |
| 04/27/2006 | WO2006044955A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | WO2006044454A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | WO2006044412A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | WO2006044355A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 04/27/2006 | WO2006044228A1 Histamine h3 receptor inhibitors, preparation and therapeutic uses |
| 04/27/2006 | WO2006043594A1 1,5-diheterocycle-1h-triazole derivative |
| 04/27/2006 | WO2006043515A1 Pyrimidine-5-carboxylic acid derivative |
| 04/27/2006 | WO2006043490A1 Pyrimidine derivative fused with nonaromatic ring |